Supply Chain

Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose material to dislodge during use, potentially leading to stroke or death.  The recall, identified as the FDA’s most serious,…

President Donald Trump announced a sweeping set of new tariffs April 2, marking one of the most significant shifts in U.S. trade policy in decades. Beginning April 5, the U.S. will implement a 10% baseline tariff on all countries. Reciprocal…

The Subcommittee on Oversight and Investigations for the House Committee on Energy and Commerce raised concerns about cybersecurity risks in aging medical devices during an April 1 hearing.  During the hearing, experts warned that outdated hardware, which can often outlast…

From tackling product back orders to streamlining inventory management, health systems are taking targeted steps to resolve key supply chain bottlenecks.  Below are responses from seven supply chain leaders who were asked: What is one specific bottleneck your health system…

In a survey of 200 healthcare industry experts, 82% said they expect tariff-related import expenses to increase hospital and health system costs by 15% in the next six months.  Black Book Market Research, a healthcare research and analysis firm, conducted…

The White House is set to impose reciprocal tariffs April 2, narrowing in on a targeted set of nations that account for the bulk of foreign trade with the U.S., The Wall Street Journal reported March 23.  President Donald Trump…

Smiths Medical recalled certain sizes of its Portex oral/nasal endotracheal tubes because of a manufacturing defect that results in a smaller diameter, which could potentially lead to inadequate ventilation.  The FDA has classified this as a Class I recall, its…

The FDA approved Humacyte’s lab-grown blood vessel Symvess despite internal warnings from agency scientists about its safety and efficacy, The New York Times reported March 24.  The decision, made in December without a public review, has sparked criticism from medical…

The FDA has issued an early alert regarding a potential safety issue with Calyxo’s CVAC Aspiration System, warning that improper use can lead to serious injury or death.  On Feb. 19, Calyxo notified healthcare providers about updated instructions for use…

Johnson & Johnson will invest $55 billion in U.S. manufacturing, research and technology over the next four years, marking a 25% increase in investment for the company.  The expansion will include four new manufacturing facilities, with the first breaking ground…